Delivery Order SPE2DB20D2001-SPE2DB24FM57A
Award Date
4/19/24
Potential Completion Date
4/22/24
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,091.04 firm fixed-price delivery order is for the supply of insulin glargine-yfgn U100 pens. The contract has an ultimate completion date of November 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,867.28 Firm Fixed Price Delivery Order is for the supply of Insulin Glargine-YFGN U100 Pens. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $4,091.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of insulin glargine-yfgn U100 pens, a critical diabetes management medication, with a completion date of December 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,683.31, is for the delivery of insulin glargine-yfgn U100 pens. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 29, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.09 firm fixed price delivery order is for the supply of INSULIN GLARGINE-YFGN U100 PEN 3ML, a critical medication for diabetes management. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.84 Firm Fixed Price Delivery Order is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical diabetes management medication. The contract has an ultimate completion date of August 22, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $2,494.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INSULIN GLARGINE-YFGN U100 PEN 3ML, classified under the federal contract description code 4566947222. The contract has an ultimate completion date of January 16, 2025, and is a Firm Fixed Price Delivery Order. AmerisourceBergen Drug Corp is the prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,343.00 Firm Fixed Price Delivery Order is for the supply of 4565826728 units of Insulin Lispro 100 Unit/mL Pen 3mL, with a completion date of September 17, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,943.52 Firm Fixed Price Delivery Order is for the supply of Insulin Aspart 100 Unit/mL vials. The contract has an ultimate completion date of April 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...
This federal contract award, valued at $2,841.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of INSULIN GLARGINE-YFGN U100 PEN 3ML, a critical pharmaceutical product, with a performance period through December 27, 2024. The contract is structured as a Firm Fixed Price Delivery Order and is not designated with any set-aside requirements, indicating open...